An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Study Summary

This study is conducted in the United States of America (USA). The aim of the study is to monitor the number of annual new adult cases of medullary thyroid carcinoma (MTC) and to establish a registry for these new cases in order to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market.

Conditions

Diabetes Diabetes Mellitus, Type 2 Medullary Thyroid Carcinoma Weight Management

Interventions / Drugs

No treatment given

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment6750 participants

Primary Completion—

Lead SponsorNovo Nordisk A/S

Data Retrieved2026-04-11 02:55:47.366879+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.